Surgery Clinical Trial
Official title:
Abdominal Hernia in Cirrhotic Patients: Surgery or Conservative Treatment?
Cirrhotic patients have a high incidence of abdominal wall hernias. Ascites and sarcopenia
are risk factors to development of bigger hernias and frequent need for urgent surgery due
parietal complications. However, hernia surgery is usually delayed in cirrhotic patients
because of high morbidity and mortality.
Methods: A prospective study of cirrhotic patients with abdominal wall hernia during January
2009 to November 2014. Demographics, characteristics of underlying liver disease, type of
hernia, complications and mortality of 246 enrolled patients were collected. Elective hernia
repair was performed in 57 unselected patients, 186 patients were kept in clinical follow
up. During follow up urgent hernia surgery was performed when unavoidable
Abdominal wall hernias are frequent in cirrhotic patients. The incidence of umbilical
hernia´s reaches over 20% in compensated cirrhosis and even 40% in patients with ascites.
Several risk factors explain the development of umbilical hernia in these patients, such as,
increased intra-abdominal pressure caused by ascites; abdominal aponeurosis weakness due
sarcopenia ; and recanalization of the umbilical vein. These hernias develop great hernial
sacs, especially when ascites is present. All these risk factors also explain their high
complication rate due to the development of pressure ulcers, skin rupture, ascites leak and
bacterial peritonitis. Moreover pain is a common associated symptom.
Inguinal hernias also develop due to higher intra-abdominal pressure due to ascites; they
often result in large hernia sacs reaching the scrotum. In addition such large hernias are
responsible for reduced mobility and quality of life.
The ideal treatment would be to correct both the abdominal wall hernia and the underlying
liver disease. However, there are insufficient liver´s donors, so the liver transplantation
(LT) waiting list continuously grows. This explains why the majority of abdominal wall
hernias in cirrhotic patients remain untreated for several years.
Therefore, most cirrhotic hernia patients are followed conservatively, the surgical
treatment being reserved when complications occur. Such expectative attitude is explained by
the high postoperative morbidity and mortality. Although, urgent surgery in such patients
impose a higher morbidity and mortality compared to elective hernia surgery.
No prospective study is reported comparing the incidence of complications in cirrhotic
hernia patients which are just observed or submitted to elective surgery. The aim of this
study is to analyze the results of the surgical treatment of abdominal wall hernias in
cirrhotic patients.
A prospective study was conducted in patients having documented cirrhosis and abdominal
hernia that were followed at the Department of Liver Transplant of University of São Paulo
during the period January 2009 to November 2014. All patients included in the study signed
an informed consent. At that moment they were randomized for elective hernia repair or
clinical follow-up accordingly to their Child-Pugh (CTP) status. Patients who developed
local hernia complications during observation underwent emergency hernia surgery.
Cirrhosis was diagnosed by liver tests and confirmed with liver imaging or biopsy. Abdominal
wall hernias were diagnosed by physical examination and ultrasound and/or CT scans when
necessary.
All patients were managed for their liver disease using individualized laboratory tests,
endoscopic and ultrasound work-up. Patients with decompensated liver disease were medically
optimized using diuretics in order to control the ascites.
Variables studied were: age, sex, etiology of liver disease, CTP classification, MELD (model
of end stage liver disease) score, ascites, need of paracentesis, diabetes mellitus, renal
failure and abdominal hernia type, morbidity and mortality. In patients who underwent
surgery length of hospital stay, post-operative complications, grade of complications
accordingly Clavien and infection were also recorded. Post-operative mortality was
considered up to 30-days. End points of the study were death, hernia recurrence or LT.
This study was approved by the Institutional Review Board of University of Sao Paulo.
Wait and see was the advocated policy before this study.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT03213314 -
HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies
|
N/A | |
Enrolling by invitation |
NCT05534490 -
Surgery and Functionality in Older Adults
|
N/A | |
Recruiting |
NCT04792983 -
Cognition and the Immunology of Postoperative Outcomes
|
||
Terminated |
NCT04612491 -
Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
|
||
Recruiting |
NCT06397287 -
PROM Project Urology
|
||
Recruiting |
NCT04444544 -
Quality of Life and High-Risk Abdominal Cancer Surgery
|
||
Completed |
NCT04204785 -
Noise in the OR at Induction: Patient and Anesthesiologists Perceptions
|
N/A | |
Completed |
NCT03432429 -
Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study
|
||
Completed |
NCT04176822 -
Designing Animated Movie for Preoperative Period
|
N/A | |
Recruiting |
NCT05370404 -
Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain:
|
N/A | |
Not yet recruiting |
NCT05467319 -
Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS
|
Phase 3 | |
Recruiting |
NCT04602429 -
Children's Acute Surgical Abdomen Programme
|
||
Completed |
NCT03124901 -
Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor
|
N/A | |
Completed |
NCT04595695 -
The Effect of Clear Masks in Improving Patient Relationships
|
N/A | |
Recruiting |
NCT06103136 -
Maestro 1.0 Post-Market Registry
|
||
Completed |
NCT05346588 -
THRIVE Feasibility Trial
|
Phase 3 | |
Completed |
NCT04059328 -
Novel Surgical Checklists for Gynecologic Laparoscopy in Haiti
|
||
Recruiting |
NCT03697278 -
Monitoring Postoperative Patient-controlled Analgesia (PCA)
|
N/A |